Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-12-11FDA Approved: GEMCITABINE — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' generic gemcitabine hydrochloride under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE Trial [Phase 2]
Phase 2 PRECISE trial evaluating rational epigenetic immunotherapy as second-line treatment for non-small cell lung cancer has completed and…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma [Phase 1, Phase 2]
Clinical trial of aflibercept with pemetrexed and cisplatin in advanced carcinoma and non-small cell lung cancer was terminated; results pos…
-
FDA approval · 2020-12-09FDA Approved: TAGRISSO — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for TAGRISSO (osimertinib) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study of LY3023414 and Necitumumab in Squamous Lung Cancer [Phase 2]
Phase 2 study of LY3023414 and necitumumab in metastatic non-small cell lung cancer was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of IBI305 in advanced or recurrent non-squamous non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Vandetanib in Advanced NSCLC With RET Rearrangement [Phase 2]
A Phase 2 clinical trial evaluating vandetanib in advanced non-small cell lung cancer with RET rearrangement has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Study of Nivolumab for Advanced Cancers in India [Phase 4]
Phase 4 trial update for nivolumab in advanced cancers conducted in India, with completed status and results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Almonertinib With Chemotherapy in mEGFR NSCLC [Phase 2]
Phase 2 clinical trial update evaluating almonertinib in combination with chemotherapy for metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Tarceva (erlotinib) with radiotherapy for locally advanced non-small cell lung cancer has completed with p…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: A Phase II Trial of Upfront Radiotherapy Plus Almonertinib for Epidermal Growth Factor Receptor(EGFR)-Mutant Non-small-cell Lung Cancer(NSCLC) Patients With Brain Metastases [Phase 2]
A Phase II trial evaluating upfront radiotherapy plus almonertinib for EGFR-mutant non-small cell lung cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura [Phase 2]
Clinical trial update for photodynamic therapy in resectable non-small cell lung cancer with pleural spread (Phase 2) shows terminated statu…
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. [Phase 3]
Phase 3 survival study for women with advanced non-small cell lung cancer who have not received chemotherapy; trial terminated.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating WX-0593 in ALK-positive or ROS1-positive non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery [Phase 3]
Phase 3 trial update investigating radiation therapy for non-small cell lung cancer that has been completely removed by surgery.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study evaluating the safety and efficacy of adding ramucirumab to nab-paclitaxel in previously treated advanced non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating anlotinib with docetaxel in wild-type advanced non-squamous non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients [Phase 2]
Phase 2 trial evaluating anlotinib plus docetaxel in EGFR-mutant advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients [Phase 2]
Phase 2a trial evaluating HL301 for efficacy and safety in radiation pneumonitis associated with lung cancer (non-small cell lung cancer). S…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating the role of postoperative radiotherapy in patients with IIIA(N2) non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC [Phase 2]
Phase 2 trial update exploring camrelizumab with chemotherapy in adults with medically inoperable early stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum [Phase 3]
Phase 3 trial evaluating GTx-024 for muscle wasting in first-line platinum-treated non-small cell lung cancer patients has completed with re…
-
FDA approval · 2020-11-09FDA Approved: ERLOTINIB — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's original ANDA for erlotinib, providing a generic version of the cancer drug.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy [Phase 2]
Phase 2 trial evaluating enzastaurin versus placebo for brain metastases from lung cancer after whole-brain radiation therapy has completed …
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial [Phase 3]
Phase 3 clinical trial update for an elderly patient individualized chemotherapy approach in stage IV non-small cell lung cancer; current st…